Podcast
Questions and Answers
What is the major cause of mortality in patients with this condition?
What is the major cause of mortality in patients with this condition?
- Dilated cardiomyopathy (correct)
- Pulmonary infiltrates
- Endomyocardial fibrosis
- Angioedema
Which of the following is not a clinical manifestation of eosinophilia?
Which of the following is not a clinical manifestation of eosinophilia?
- Pruritus
- Cough
- Gastrointestinal bleeding (correct)
- Diarrhea
How can one define myeloid HE/HES?
How can one define myeloid HE/HES?
- Eosinophilia due to helminth infection
- Suspected or proven eosinophilic myeloid neoplasm (correct)
- Presence of a clonal T-cell population
- Eosinophilic disorders overlapping with idiopathic HES
Which clinical involvement is unlikely to result from eosinophilia?
Which clinical involvement is unlikely to result from eosinophilia?
What is a characteristic feature of overlap HES?
What is a characteristic feature of overlap HES?
Which mediator is primarily involved in local tissue damage due to eosinophilia?
Which mediator is primarily involved in local tissue damage due to eosinophilia?
Which classification of HE/HES is associated with infections or neoplasms?
Which classification of HE/HES is associated with infections or neoplasms?
What neurological condition can eosinophilia lead to?
What neurological condition can eosinophilia lead to?
What should patients with LHES be assessed for at diagnosis?
What should patients with LHES be assessed for at diagnosis?
What blood test is recommended to evaluate the presence of myeloid precursors?
What blood test is recommended to evaluate the presence of myeloid precursors?
Which test can indicate the presence of malignant hypereosinophilia syndrome (MHES)?
Which test can indicate the presence of malignant hypereosinophilia syndrome (MHES)?
What is a common characteristic of clonal T-cell populations found in certain conditions?
What is a common characteristic of clonal T-cell populations found in certain conditions?
Which condition is characterized by elevated serum IgM levels?
Which condition is characterized by elevated serum IgM levels?
What condition is indicated by elevated serum tryptase levels?
What condition is indicated by elevated serum tryptase levels?
What encompasses the comprehensive history and physical examination for HE diagnosis?
What encompasses the comprehensive history and physical examination for HE diagnosis?
Which statement is true regarding lymphocyte phenotyping by flow cytometry?
Which statement is true regarding lymphocyte phenotyping by flow cytometry?
What was the initial treatment administered for presumed idiopathic thrombocytopenic purpura?
What was the initial treatment administered for presumed idiopathic thrombocytopenic purpura?
What was the result of the testing for FIP1L1::PDGFRA?
What was the result of the testing for FIP1L1::PDGFRA?
During the treatment phase, what condition did the patient experience after tapering prednisone?
During the treatment phase, what condition did the patient experience after tapering prednisone?
Which laboratory finding was NOT noted during the physical examination of the patient?
Which laboratory finding was NOT noted during the physical examination of the patient?
What was the diagnosis made after T-cell receptor testing and flow cytometry?
What was the diagnosis made after T-cell receptor testing and flow cytometry?
What treatment was initiated after referral to the National Institutes of Health?
What treatment was initiated after referral to the National Institutes of Health?
Which clinical symptom did the patient experience during her assessment before treatment at the National Institutes of Health?
Which clinical symptom did the patient experience during her assessment before treatment at the National Institutes of Health?
What was the peak absolute eosinophil count (AEC) recorded during the treatment?
What was the peak absolute eosinophil count (AEC) recorded during the treatment?
What characterizes myeloproliferative variant HES in terms of its clinical features?
What characterizes myeloproliferative variant HES in terms of its clinical features?
Which treatment option has shown effectiveness in patients with myeloproliferative variant HES due to the FIP1L1–PDGFRA fusion gene?
Which treatment option has shown effectiveness in patients with myeloproliferative variant HES due to the FIP1L1–PDGFRA fusion gene?
How does lymphocytic variant HES typically present in most patients?
How does lymphocytic variant HES typically present in most patients?
What is the initial therapeutic approach for a case of eosinophilia associated with a helminth infection?
What is the initial therapeutic approach for a case of eosinophilia associated with a helminth infection?
What is the gold standard for diagnosing lymphocytic variant HES?
What is the gold standard for diagnosing lymphocytic variant HES?
What is the mainstay therapy for severe and/or life-threatening manifestations of Hypereosinophilia Syndrome (HES)?
What is the mainstay therapy for severe and/or life-threatening manifestations of Hypereosinophilia Syndrome (HES)?
Which factor should be assessed to determine the urgency of intervention in eosinophilia cases?
Which factor should be assessed to determine the urgency of intervention in eosinophilia cases?
Which statement regarding lymphocytic variant HES is accurate?
Which statement regarding lymphocytic variant HES is accurate?
Which of the following is NOT a feature of myeloproliferative variant HES?
Which of the following is NOT a feature of myeloproliferative variant HES?
In cases of hypereosinophilia where symptoms do not improve within 24 to 48 hours after starting treatment, what is the next recommended action?
In cases of hypereosinophilia where symptoms do not improve within 24 to 48 hours after starting treatment, what is the next recommended action?
What percentage of patients with lymphocytic variant HES may progress to a lymphoid malignancy?
What percentage of patients with lymphocytic variant HES may progress to a lymphoid malignancy?
What limitation exists regarding the use of corticosteroids in the long-term treatment of symptomatic HES?
What limitation exists regarding the use of corticosteroids in the long-term treatment of symptomatic HES?
Which of the following elevates in most patients with lymphocytic variant HES?
Which of the following elevates in most patients with lymphocytic variant HES?
For which subtype of HES is imatinib specifically indicated?
For which subtype of HES is imatinib specifically indicated?
How do eosinophil-targeting biologics work in the treatment of hypereosinophilia?
How do eosinophil-targeting biologics work in the treatment of hypereosinophilia?
In the clinical case provided, what was the most significant blood count finding that led to the referral to hematology?
In the clinical case provided, what was the most significant blood count finding that led to the referral to hematology?
What is defined as hypereosinophilia?
What is defined as hypereosinophilia?
Which of the following is NOT typically associated with hypereosinophilic syndromes?
Which of the following is NOT typically associated with hypereosinophilic syndromes?
Which of these conditions can lead to significant eosinophilia?
Which of these conditions can lead to significant eosinophilia?
What defines eosinophilia in the general population?
What defines eosinophilia in the general population?
According to the WHO, how long must AEC be greater than 1.5 × 10^9/L to classify as HES?
According to the WHO, how long must AEC be greater than 1.5 × 10^9/L to classify as HES?
Which of the following best describes end-organ damage as it relates to HES?
Which of the following best describes end-organ damage as it relates to HES?
Which neoplastic conditions are commonly associated with hypereosinophilia?
Which neoplastic conditions are commonly associated with hypereosinophilia?
Which of the following infections is the most common etiology for marked eosinophilia worldwide?
Which of the following infections is the most common etiology for marked eosinophilia worldwide?
Which autoimmune disorder is mentioned as potentially causing eosinophilia?
Which autoimmune disorder is mentioned as potentially causing eosinophilia?
Which condition would least likely present with hypereosinophilia?
Which condition would least likely present with hypereosinophilia?
What is the implication of the term 'idiopathic' in hypereosinophilic syndromes?
What is the implication of the term 'idiopathic' in hypereosinophilic syndromes?
Which of these conditions would most likely lead to eosinophilia as a side effect?
Which of these conditions would most likely lead to eosinophilia as a side effect?
Which of the following is classified under rare hypereosinophilic syndromes?
Which of the following is classified under rare hypereosinophilic syndromes?
What would tissue hypereosinophilia typically indicate?
What would tissue hypereosinophilia typically indicate?
Flashcards
Hypereosinophilic Syndrome (HES)
Hypereosinophilic Syndrome (HES)
A condition characterized by an abnormally high number of eosinophils in the blood and tissues. It can affect various organs, leading to diverse symptoms and potentially severe complications.
Cardiac involvement in HES
Cardiac involvement in HES
The most common cause of death in HES. It can manifest as endomyocardial fibrosis, pericarditis, myocarditis, and intramural thrombus formation, often leading to dilated cardiomyopathy.
Neurological involvement in HES
Neurological involvement in HES
Infiltration and damage caused by HES in the central and peripheral nervous systems. This can lead to a variety of neurological symptoms.
Idiopathic HES
Idiopathic HES
Signup and view all the flashcards
Lymphocytic Variant HES
Lymphocytic Variant HES
Signup and view all the flashcards
Myeloid HES
Myeloid HES
Signup and view all the flashcards
Familial HES
Familial HES
Signup and view all the flashcards
Associated HES
Associated HES
Signup and view all the flashcards
Myeloproliferative variant HES
Myeloproliferative variant HES
Signup and view all the flashcards
FIP1L1–PDGFRA fusion gene
FIP1L1–PDGFRA fusion gene
Signup and view all the flashcards
FIP1L1–PDGFRA fusion protein
FIP1L1–PDGFRA fusion protein
Signup and view all the flashcards
Interleukin-4 (IL-4)
Interleukin-4 (IL-4)
Signup and view all the flashcards
Interleukin-5 (IL-5)
Interleukin-5 (IL-5)
Signup and view all the flashcards
Angioimmunoblastic T-cell lymphoma
Angioimmunoblastic T-cell lymphoma
Signup and view all the flashcards
Cutaneous T-cell lymphoma
Cutaneous T-cell lymphoma
Signup and view all the flashcards
Eosinophilia
Eosinophilia
Signup and view all the flashcards
Eosinophil-targeting biologics
Eosinophil-targeting biologics
Signup and view all the flashcards
Prednisone
Prednisone
Signup and view all the flashcards
Eosinophilic granulomatosis with polyangiitis (EGPA)
Eosinophilic granulomatosis with polyangiitis (EGPA)
Signup and view all the flashcards
Approach to HES treatment
Approach to HES treatment
Signup and view all the flashcards
Eosinophil
Eosinophil
Signup and view all the flashcards
Pruritus
Pruritus
Signup and view all the flashcards
Löffler's Endomyocardial Fibrosis (LEMF)
Löffler's Endomyocardial Fibrosis (LEMF)
Signup and view all the flashcards
Idiopathic Hypereosinophilic Syndrome (IHES)
Idiopathic Hypereosinophilic Syndrome (IHES)
Signup and view all the flashcards
PDGFRα and KIT-associated HES
PDGFRα and KIT-associated HES
Signup and view all the flashcards
Lymphoma-associated Hypereosinophilic Syndrome (LHES)
Lymphoma-associated Hypereosinophilic Syndrome (LHES)
Signup and view all the flashcards
Eosinophil count
Eosinophil count
Signup and view all the flashcards
Blood smear
Blood smear
Signup and view all the flashcards
Genetic testing (PDGFRα and KIT genes)
Genetic testing (PDGFRα and KIT genes)
Signup and view all the flashcards
What are Hypereosinophilic Syndromes (HES)?
What are Hypereosinophilic Syndromes (HES)?
Signup and view all the flashcards
What is the definition of hypereosinophilia?
What is the definition of hypereosinophilia?
Signup and view all the flashcards
How common is hypereosinophilia?
How common is hypereosinophilia?
Signup and view all the flashcards
What are some atopic disorders associated with mild eosinophilia?
What are some atopic disorders associated with mild eosinophilia?
Signup and view all the flashcards
What is drug hypersensitivity and its relation to eosinophilia?
What is drug hypersensitivity and its relation to eosinophilia?
Signup and view all the flashcards
What are some infectious causes of hypereosinophilia?
What are some infectious causes of hypereosinophilia?
Signup and view all the flashcards
What autoimmune disorders can be associated with eosinophilia?
What autoimmune disorders can be associated with eosinophilia?
Signup and view all the flashcards
What types of cancers can be associated with hypereosinophilia?
What types of cancers can be associated with hypereosinophilia?
Signup and view all the flashcards
What are some inborn errors of immunity associated with eosinophilia?
What are some inborn errors of immunity associated with eosinophilia?
Signup and view all the flashcards
What are some rare hypereosinophilic syndromes?
What are some rare hypereosinophilic syndromes?
Signup and view all the flashcards
What are some other miscellaneous causes of hypereosinophilia?
What are some other miscellaneous causes of hypereosinophilia?
Signup and view all the flashcards
What is the WHO definition of hypereosinophilic syndrome?
What is the WHO definition of hypereosinophilic syndrome?
Signup and view all the flashcards
What is the consensus definition of hypereosinophilic syndrome?
What is the consensus definition of hypereosinophilic syndrome?
Signup and view all the flashcards
What is Idiopathic Hypereosinophilic Syndrome?
What is Idiopathic Hypereosinophilic Syndrome?
Signup and view all the flashcards
What is primary (clonal/neoplastic) hypereosinophilic syndrome?
What is primary (clonal/neoplastic) hypereosinophilic syndrome?
Signup and view all the flashcards
Serologic Test
Serologic Test
Signup and view all the flashcards
Hydroxyurea
Hydroxyurea
Signup and view all the flashcards
Interferon α
Interferon α
Signup and view all the flashcards
Absolute Eosinophil Count (AEC)
Absolute Eosinophil Count (AEC)
Signup and view all the flashcards
Computed Tomography (CT) Scan
Computed Tomography (CT) Scan
Signup and view all the flashcards
Bone Marrow Biopsy
Bone Marrow Biopsy
Signup and view all the flashcards
Splenomegaly
Splenomegaly
Signup and view all the flashcards
T-cell
T-cell
Signup and view all the flashcards
B-cell
B-cell
Signup and view all the flashcards
Ultrasound
Ultrasound
Signup and view all the flashcards
Immunoglobulin
Immunoglobulin
Signup and view all the flashcards
IgE
IgE
Signup and view all the flashcards
MRI (Magnetic Resonance Imaging)
MRI (Magnetic Resonance Imaging)
Signup and view all the flashcards
IgG
IgG
Signup and view all the flashcards
IgM
IgM
Signup and view all the flashcards
Ivermectin
Ivermectin
Signup and view all the flashcards
Albendazole
Albendazole
Signup and view all the flashcards
Tryptase
Tryptase
Signup and view all the flashcards
Cytokine
Cytokine
Signup and view all the flashcards
Edema
Edema
Signup and view all the flashcards
FIP1L1::PDGFRA
FIP1L1::PDGFRA
Signup and view all the flashcards
KIT
KIT
Signup and view all the flashcards
D816V KIT
D816V KIT
Signup and view all the flashcards
Study Notes
Hypereosinophilic Syndromes (HES)
- HES is a heterogeneous group of rare disorders with diverse clinical manifestations, ranging from fatigue to life-threatening conditions like endomyocardial fibrosis and thromboembolic events.
Eosinophilia
- Eosinophilia, characterized by an absolute eosinophil count (AEC) greater than 0.45 x 10^9/L, is relatively common, occurring in 1% to 2% of the general population.
- Hypereosinophilia (HE), with an AEC greater than 1.5 x 10^9/L, is extremely rare, with an estimated incidence of 0.315 to 6.3 per 100,000 in the United States.
Disorders Associated with Marked Eosinophilia
- Atopic disorders: Asthma, atopic dermatitis, chronic rhinosinusitis
- Drug hypersensitivity: Various drug reactions, including drug rash with eosinophilia and systemic symptoms (DRESS), and eosinophilia-myalgia syndrome.
- Infection and infestation: Helminth infections (particularly those with a tissue invasive phase), fungal infections, viral infections (including HIV and COVID-19), ectoparasite infestations, and protozoal infections (limited to Sarcocystis and Cystoisospora).
- Autoimmune and immunodysregulatory disorders: Inflammatory bowel disease, sarcoidosis, and IgG4-related disease.
- Neoplasia: Leukemia, lymphoma
- Inborn errors of immunity: Omenn syndrome, DOCK8 deficiency, Loeys-Dietz syndrome, eosinophilic myeloid neoplasms, lymphocytic variant HES, idiopathic HE/HES, familial HE/HES, single-organ HE/HES, etc.
Classification of HES
-
Myeloid HES: Suspected or proven eosinophilic myeloid neoplasm, including cases associated with rearrangements of PDGFRA.
-
Lymphocytic variant HE/HES: Presence of a clonal or phenotypically aberrant T-cell population that produces cytokines driving the eosinophilia.
-
Overlap HES: Single-organ-restricted eosinophilic disorders or eosinophilic syndromes that overlap clinically with idiopathic HES, including eosinophilic gastrointestinal disorders and eosinophilic granulomatosis with polyangiitis (EGPA).
-
Associated HE/HES: HES occurring in the context of a defined disorder (e.g., helminth infection, neoplasm, immunodeficiency, or hypersensitivity reaction).
-
Familial HE/HES: Presence in more than one family member (excluding cases with associated HE/HES).
-
Idiopathic HE/HES: Unknown cause, excluding other types.
CLINICAL MANIFESTATIONS
- Constitutional Symptoms: fatigue, muscle aches, fevers, pruritus, angioedema, diarrhea, and cough
- Cardiac involvement: endomyocardial fibrosis, pericarditis, myocarditis, and intramural thrombus formation, often leading to dilated cardiomyopathy, and is a major cause of mortality.
- Involvement of the nervous system: mononeuritis multiplex, paraparesis, encephalopathy, and dementia.
- Pulmonary involvement: pulmonary infiltrates, fibrosis, or pleural disease with effusions
- Gastrointestinal involvement: diarrhea, gastritis, colitis, hepatitis, or Budd-Chiari syndrome
- Skin involvement: pruritus, angioedema, papules, or plaques
- Other tissues: rarely kidneys and bones
Pathophysiology
- Tissue damage in eosinophilia is believed to be secondary to eosinophil degranulation, releasing mediators like cationic protein and major basic protein, primarily acting locally in infiltrated tissues to trigger damage.
- Serum tryptase may be elevated in some cases with clonal eosinophilia, suggesting a possible role for mast cells.
Diagnositc Workup
- Comprehensive History & Physical Exam
- Complete Blood Count (CBC) with differential & smear
- Routine Chemistries including liver function tests
- Quantitative Serum Immunoglobulins (e.g., IgM, IgE)
- Serum Tryptase and B12 levels
- Flow cytometry for aberrant T-cells.
- Bone marrow aspirate and biopsy
- T- and B-cell receptor rearrangement studies
Approach to Therapy
- Secondary causes (e.g., infections) should be considered and addressed early.
- The presence of clinical manifestations should guide the urgency and nature of treatment.
- Prednisone is the initial treatment for severe or life-threatening HES.
- Alternative therapies include imatinib for myeloid neoplasms, cyclophosphamide for EGPA, hydroxyurea, and interferon-α, or specialized eosinophil-targeting biologics like mepolizumab and Reslizumab.
- Patient stability should be continually monitored and additional treatments considered as needed.
Case Studies
- Case studies are presented demonstrating varying approaches to diagnosis and treatment based on different presentations of clinical manifestations.
- Additional tests like Bone marrow and PET/CT are crucial for the approach to the patient
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Explore the complexities of Hypereosinophilic Syndromes (HES) and the various disorders associated with eosinophilia. This quiz covers clinical manifestations, prevalence, and relevant atopic disorders linked to eosinophilia. Test your knowledge on this unique group of rare disorders.